Development of Motility and Cognition in Infants

Recruiting Observational Study
Neurodevelopmental Disorders Developmental Delay Development, Infant Child Development Cognitive Developmental Delay Neurophysiologic Abnormality
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
5 Months – 26 Months
Sex
Any
Study type
Observational
Participants needed
250 (estimated)
Sponsor
Helsinki University Central Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

PILKE study uses wearables for assessing motor development in infants in order to define functional growth trajectories in the normal infants and infants at risk of neurological compromise. In addition, PILKE studies correlation of early motor development to later neurocognitive development.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * age at enrollment 5-8mos * typically developing Exclusion Criteria: * all neurologically significant medical histories during pregnancy, at birth or postnatally * suspicion of developmental delay * suspicion or diagnosis of syndromes with neuromotor symptoms
Contacts

Sampsa Vanhatalo, prof

00358505286119

sampsa.vanhatalo@helsinki.fi

CONTACT

Leena Haataja, prof

00358504272069

leena.haataja@hus.fi

CONTACT